Evaluation of Precancerous Breast Lesion Upgrade Rate

  1. Esmat Alsadat Hashemi ,
  2. Shahpar Haghighat ,
  3. Asieh Olfatbakhsh ,
  4. Maryam Jafari ,
  5. Mehrdad Yasaei

Vol 6 No 4 (2021)

DOI 10.31557/apjcc.2021.6.4.461-466

Abstract

Background: Breast imaging guided core-needle biopsy enable the assessment of suspected precancerous lesions. In some precancerous lesion there is a risk of upgrading to cancer after surgical removal. This study was conducted to determine the upgrading rate of CNB-diagnosed precancerous breast lesions.
Methods: A retrospective study was conducted to examine the data of patients who had undergone core needle biopsy from April 2016 to March 2019 at the Radiology Department of the Breast Clinic of Motamed Cancer Institute and whose pathological reports were indicative of a precancerous lesion such as atypical ductal hyperplasia, sclerosing adenosis, flat epithelial atypia or papillary lesion and had undergone surgery for this lesion. The upgrading rate and its related factors such as the size of the lesion, patient’s age, family history of breast cancer and method of core-needle biopsy were analyzed in SPSS software.
Results: A total of 241 patients were recruited with a pathological report of pre-cancerous predisposing lesions. The mean age of the patients was 42.14 years and the highest upgrading rates in the analysis were observed for papillary lesion (19.3%) and atypical ductal hyperplasia, (21.4%), while the upgrading rates were (1.2% ) for sclerosing adenosis and (0%) for flat epithelial atypia. Data analysis showed that the lesions’ upgrading rate correlated with the lesion’s size (P=0.005).
Conclusion: The findings of this study showed that size of the lesions increase the risk of upgrading to cancer, which is much higher in papillary lesion and atypical ductal hyperplasia compared to sclerosing adenosis and flat epithelial atypia. It seems that surgical excision of the entire lesion in patients with larger mass size may decrease the upgrading rate of cancer. Conducting specific studies on each distinct lesion can help yield more conclusive results. 

Introduction

About 10% of patients who undergo screening mammography for breast cancer show an indication for additional imaging techniques. In approximately 8-10% of these cases, the findings may lead to breast biopsy. These findings can be reported as the presence of a mass, microcalcification, architectural distortion or focal asymmetry, which are construed as indications for additional imaging. The radiologist may report the existing lesion as suspicious and recommend a biopsy based on the results of these additional imaging techniques. In the case of non-palpable breast lesions, the standard method is Core Needle Biopsy (CNB) guided by either of the imaging techniques including mammography, ultrasound and MRI.

CNB can be either conventional or vacuum-assisted and be guided by ultrasound or mammography (stereotactic). CNB is the standard method for the diagnosis of suspected lesions in the breast and is less costly compared to surgery and yields results that are consistent with the pathological report obtained by surgical biopsy in 95% of the cases [1-3].

The pathology report of CNB can determine whether there is a need for surgery in the patient. An important point is the conformity of the pathology and radiology findings. If a radiologist reports a lesion suspected of cancer but the pathologic findings indicate a benign lesion, surgery will be necessary for definitive diagnosis. In some cases, the pathology report may suggest a pre-cancerous lesion such as Atypical Ductal Hyperplasia (ADH), Sclerosing Adenosis (SA), Flat Epithelial Atypia (FEA) or Papillary Lesion (PL), which have indications for surgery in order to reduce the risk of future cancer and to get a more precise diagnosis. Post-surgical pathology reports may be similar to the initial pathological report or may be worse and indicate invasive cancer.

Sclerosing Adenosis (SA) is one of the benign lesions that may be identified in CNB pathology reports; despite its high prevalence, this lesion is not well-known. In pathological terms, this proliferative lesion is associated with an increase in convoluted lobules and stromal fibrosis. Several studies have investigated the association of SA with breast cancer and have revealed different results [4]. Also, in some cases, the pathology report following surgery may reveal a more severe condition compared to CNB. ADH is one of these proliferative lesions that develop in the mammary epithelial tissue. The presence of this lesion in the breast increases the risk of invasive cancer in the breast four- or five-fold. Various studies have reported a 7-87% discrepancy between CNB pathology and surgical pathology with respect to the presence of non-invasive or invasive cancer in ADH [5-11]. In other words, the upgrading rate of the lesions in different studies is highly variable. At the same time, due to the high risk of breast cancer development in these lesions, it is reasonable to recommend surgical removal to prevent this risk when

ADH is confirmed by CNB [12-13].

Papillary lesion (PL) is a benign lesion with a lower prevalence in the breast that is seen in the ultrasound as a single lesion or multiple lesions. In some cases, the patient does not have any specific clinical symptoms, while in some patients, blood or serous fluid secreted from the nipple raises suspicion, which can then be confirmed by an ultrasound. In these cases, too, the patient can undergo CNB. Previous studies have reported the upgrading rate of these lesions after surgery as 11% [14].

Flat epithelial atypia (FEA) is a new diagnostic term that is expressed in pathologic reports following CNB and is usually associated with other benign or malignant breast lesions. Due to this association, when this lesion is present in the pathology report following CNB, the site of the lesion is recommended to be removed with surgery, particularly if detected in the mammography despite microcalcification and if, after sampling, calcium deposits are still detected in the control mammogram [15-16]. According to studies, four cases of breast cancer are reported in the post-surgical pathology in every 1,000 patients [17-19].

The present study was designed in view of the differences of opinion about upgrading rates after surgery and the need for more extensive interventions. The results can guide the surgeon’s decision for surgical procedures and the rate of tissue removal and, at the same time, help present preventive therapies for patients who are prone to breast cancer.

Materials and Methods

This cohort study was conducted on candidates of CNB guided by one of the imaging techniques due to a suspicious lesion observed in the ultrasound or mammogram who had then undergone surgery within a maximum of one month at the Breast Clinic of Motamed Cancer Institute, Culture and Research. Data on the imaging reports, post-CNB pathology and post-surgical pathology were collected and compared. Upgrading rate in different studies had been reported between 7 – 87 percent [5-11]. So upgrading rate, α error and absolute precision of current study were considered equal to 0.47, 0.05 and 0.07, respectively and 198 samples was the sample size were estimated 198 patients.

Breast Clinic of Motamed Cancer Institute is a multidisciplinary center in Tehran. Referred patients are examined by surgeons and different diagnostic and treatment modalities are achieved according to its updated guideline [12].

Of the 2582 patients who had undergone CNB guided by one of the imaging techniques from April 2017 to March 2020 at the Radiology Department of the Breast Clinic of Motamed Cancer Institute, 241 whose pathologic reports indicated one of the listed pre-cancerous lesions and had their lesion surgically removed by a surgeon and whose medical files were complete were recruited.

Definition of upgrading

A change in any of the pre-cancerous lesions diagnosed as Atypical Ductal Hyperplasia (ADH), Sclerosing Adenosis (SA), Flat Epithelial Atypia (FEA) or Papillary Lesion (PL) to in-situ or invasive carcinoma in the post-surgical pathology is considered an instance of upgrade. Since the transformation of any of the noted pre-cancerous lesions to ADH is considered an upgrade and deems breast cancer preventive measures necessary, the upgrade of FEA, SA and PL detected in the surgery as ADH was also considered a general instance of upgrade. This study was conducted to examine the relationship between demographic and clinical variables, including the patient’s age, family history of breast cancer, size of the mass, biopsy method, pathology according to CNB, pathology according to the surgery and the upgrading rate of the lesion. The study was accepted in scientific committee of Breast Cancer Research Center and received the ethics committee approval (code No. IR.ACECR. IBCRC. REC.1394.47).

Statistical analysis

The absolute and relative frequency of demographic and clinical characteristics and upgrading rates were reported by descriptive statistical tests. The relationship of upgrading rate with other variables was analyzed by Pearson Chi-Square and Fisher’s Exact Tests.

Results

The mean age of the patients was 42.14 (±9.8) years. Table 1 presents the frequency of each of the variables. The most frequent pre-cancerous lesion in the CNB (49.4%) was PL, 23 (19.3%) of which were diagnosed as cancer in the surgical pathology.

Table 1. The Absolute and Relative Frequency of the Demographic and Clinical Variables in the Subjects (n=241).

Variable Number Percentage
Age (year)    
<30 29 12
30-50 180 74.7
>50 32 13.3
Family history of breast cancer    
Positive 43 17.8
Negative 198 82.2
Size of the lesion (cm)    
=<2 226 93.8
>2-5 15 6.2
Biopsy method    
CNB*** 208 86.3
Vacuum-assisted CNB 25 10.4
Stereotactic CNB 8 3.3
Biopsy pathology    
ADH 28 11.6
SA 83 34.4
FEA 11 4.6
PL 119 49.4
Surgical pathology**    
ADH 17 7.1
SA 67 27.8
FEA 7 2.9
PL 84 34.9
Carcinoma 19 7.9
Other benign lesions * 47 19.5

* Other benign lesions, Fibroadenoma, Fibrocystic changes, Phyllodes tumor; **Atypical Ductal Hyperplasia (ADH), Sclerosing Adenosis (SA), Flat Epithelial Atypia (FEA), Papillary Lesion (PL); ***Core Needle Biopsy (CNB)

According to the findings of Table 2, the upgrading rate of the lesions was also different of lesions. The highest upgrading rate were noticed in ADH (21.4%) and PL (19.3%) and the lowest rates (1% and 0%) in SA and FEA, respectively (p-value = 0.033).

Table 2. The Upgrading Rate in Each of the Pre-cancerous Lesions.

Upgrading     Biopsy Pathology*    
  ADH SA FEA PL Total
Negative 22 82 11 96 211
  78.60% 98.80% 100% 80.70% 87.60%
Positive 6 1 0 23 30
  21.40% 1.20% 0% 19.30% 12.40%
Total 28 83 11 119 241
  100% 100% 100% 100% 100%

*Atypical Ductal Hyperplasia (ADH), Sclerosing Adenosis (SA), Flat Epithelial Atypia (FEA), Papillary Lesion (PL)

The second part of the data analysis examined the relationship of each study variable with the upgrading rate using Pearson Chi-Square and Fisher’s Exact Test (Table 3).

Table 3. The Relationship between Upgrading and Demographic and Clinical Variables.

Variable Upgrading Frequency (Percentage)   P-Value
  Yes No  
Age (year)     0.088 **
<50 21 (10.8) 174 (89.2)  
≥50 9 (19.6) 37 (80.4)  
Family history of breast cancer     0.546**
Positive 5 (11.6) 38 (88.4)  
Negative 25 (12.6) 173 (87.4)  
Size of the lesion (cm)     <0.005**
=<2 24 (10.6) 202 (89.4)  
>2-5 6 (40) 9 (60)  
Biopsy method     0.550*
CNB 27 (13.0) 181 (87)  
Vacuum-Assisted/Stereotactic 3 (12.0) 30 (88)  

*Pearson Chi-Square Test, **Fisher's Exact Test

The findings of this table show that the upgrading rate was higher in patients with a lesion larger than 2 cm compared to those with a lesion smaller than or equal to 2 cm. The results of this analysis showed a significant relationship between size of the lesion and upgrading rate at the significance level of 5% (P = 0.005).

Also, according to the findings of the study, the upgrading rate was higher in patients over age 50 compared to patients younger than 50 (P=0.088).

As for family history of breast cancer, as shown in Table 3, the upgrading rate was higher in patients with a positive family history compared to those with a negative family history; however, this correlation was not significant (P=0.546).

As for CNB method, the upgrading rate was higher in the conventional CNB method compared to vacuum-assisted and stereotactic CNB; however, this correlation was not significant at the significance level of 0.05 (P=0.55).

Discussion

Benign breast conditions include a wide range of histopathologic lesions. Of the many benign types of these lesions, only a small number are clinically considered pre-cancerous or predisposing lesions of breast cancer.

A history of benign lesion biopsy in a patient’s breast, especially if the result of the pathology has shown a proliferative lesion, suggests an increased risk of breast cancer in the future.

The present study was conducted to determine the upgrading rate of pre-cancerous lesions and the factors affecting it and examined 241 women who had undergone CNB guided by mammography or ultrasound followed by a surgery at the Radiology Clinic of the Breast Clinic of the Academic Center for Education, Culture, and Research. The results show that the upgrading rate was the highest for Pl (19.3%) and ADH (21.4%) and the lowest (1%) for SA and (0%) for FEA, which is somewhat similar to the results obtained by Chae and Mooney, who reported the upgrading rate for ADH as 22.2% and 18%, respectively [13, 20]. According to a study by Dyrstad suggesting a 3.93-fold increase in the risk of breast cancer in proliferative lesions, preventive therapeutic measures can only be recommended to these patients if the upgrading rate obtained in this study for ADH and PL are taken into consideration [21]. Obviously, the presence of other risk factors of breast cancer in the patient, such as a high density of mammary tissue in the mammography, necessitates the use of additional diagnostic methods and ultimately surgery for the removal of the suspicious lesion in order to reduce the risk of cancer [22-24]. Particularly in cases where there is a discrepancy between the results of imaging and CNB, the physician should candidate the patient for the surgical removal of the lesion [25].

In cases where CNB indicates a papillary lesion in the breast, the probability of CNB errors in detecting papillary cancer in these lesions should be taken into account as well [26-27]. In papillary lesions, especially if combined with atypia, or if conventional CNB has been administered, it is advisable to remove the lesion by surgery. Some studies have shown evidence of cancerous lesions along with these lesions and advised to remove these lesions with proper margins [28-31].

In the present study, the upgrading rate for papillary lesions was 19.3%, which is less than that reported in previous studies (0 to 29%), which might be due to the smaller sample size from each of the pre-cancerous lesions in this study [32]. The biopsy method also affects the upgrading rate. This study found a lower upgrading rate in the patients undergone vacuum-assisted CNB compared to those undergone conventional CNB (12% vs. 13%), which could be related to the volume of extracted tissue as per the explanations. Seely et al. suggested that, in cases where the lesion is small and not associated with atypia and when vacuum-assisted biopsy is used, the surgery decision may be disclaimed and the patient might be put under periodical monitoring [33].

In the case of SA and FEA, the upgrading rate was 1.2% & 0% in this study, which, given the wide range of upgrading rates obtained for these lesions in different studies (0-35%), means a difference of opinion about whether to remove these lesions or put the patient under regular monitoring observe. The different upgrading rates of these lesions in the present study might be due to the small sample size in each of the pre-cancerous lesions compared to the other studies, which have examined only one type of lesion. In some cases, however, these lesions are associated with other pre-cancerous lesions that may not be detected in conventional CNB. In these instances, the patient’s age, positive family history of breast cancer or size of the lesion may be important factors in the surgeon’s choice of treatment. Since vacuum-assisted CNB yielded more precise results, it helps offer the patient better recommendations.

In conclusion, Overall, the results of this study showed that, in patients with large lesions and a pathology report of ADH or PL, the probability of upgrading is higher and the patient must undergo surgery to remove the lesion. In the case of SA or FEA, a proper decision needs to be made according to each patient’s particular circumstances for reducing the risk of future cancer. Unnecessary surgeries may be preventable by periodic follow-ups in some low- risk cases. However, we acknowledge that the number of cases in our study for each pre-cancerous lesion was not large enough. Further studies with larger sample sizes are necessary for obtaining more accurate results.

Acknowledgmens

None declared.

References


  1. Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions DahlstromJ, J, SuttonS, S, JainS S. Histopathology.1996;28(6). CrossRef
  2. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Jackman R J, Nowels K W, Shepard M J, Finkelstein S I, Marzoni F A. Radiology.1994;193(1). CrossRef
  3. Nonpalpable breast lesions: stereotactic automated large-core biopsies. Parker S H, Lovin J D, Jobe W E, Burke B J, Hopper K D, Yakes W F. Radiology.1991;180(2). CrossRef
  4. Sclerosing adenosis and risk of breast cancer Visscher Daniel W., Nassar Aziza, Degnim Amy C., Frost Marlene H., Vierkant Robert A., Frank Ryan D., Tarabishy Yaman, Radisky Derek C., Hartmann Lynn C.. Breast Cancer Research and Treatment.2014;144(1). CrossRef
  5. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. Liberman L, Cohen M A, Dershaw D D, Abramson A F, Hann L E, Rosen P P. American Journal of Roentgenology.1995;164(5). CrossRef
  6. Atypical Ductal Hyperplasia in Breast Core Needle Biopsies Renshaw Andrew A., Cartagena Norberto, Schenkman Randy H., Derhagopian Robert P., Gould Edwin W.. American Journal of Clinical Pathology.2001;116(1). CrossRef
  7. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis Harvey Jennet M., Sterrett Gregory F., Frost Felicity A.. Pathology.2002;34(5). CrossRef
  8. Histopathologic Analysis of Atypical Lesions in Image-Guided Core Breast Biopsies Bonnett Michelle, Wallis Tracie, Rossmann Michelle, Pernick Nat L., Bouwman David, Carolin Kathryn A., Visscher Daniel. Modern Pathology.2003;16(2). CrossRef
  9. Atypical Ductal Hyperplasia: Can Some Lesions Be Defined as Probably Benign after Stereotactic 11-gauge Vacuum-assisted Biopsy, Eliminating the Recommendation for Surgical Excision? Jackman Roger J., Birdwell Robyn L., Ikeda Debra M.. Radiology.2002;224(2). CrossRef
  10. Core Biopsy of the Breast With Atypical Ductal Hyperplasia Ely Kim A., Carter Beverley A., Jensen Roy A., Simpson Jean F., Page David L.. The American Journal of Surgical Pathology.2001;25(8). CrossRef
  11. Atypical Ductal Hyperplasia Diagnosis by Directional Vacuum-Assisted Stereotactic Biopsy of Breast Microcalcifications Sneige Nour, Lim Sung C., Whitman Gary J., Krishnamurthy Savitri, Sahin Aysegul A., Smith Terry L., Stelling Carol B.. American Journal of Clinical Pathology.2003;119(2). CrossRef
  12. Clinical guidelines for diseases of the breast. Breast Cancer Research Center. ACECR Third edition 2018..
  13. Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy Chae Byung, Lee Ahwon, Song Byung, Jung Sang. World Journal of Surgical Oncology.2009;7(1). CrossRef
  14. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. Lakhani S R, Collins N, Stratton M R, Sloane J P. Journal of Clinical Pathology.1995;48(7). CrossRef
  15. Management of Clinically and Mammographically Occult Benign Papillary Lesions Diagnosed at Ultrasound-Guided 14-Gauge Breast Core Needle Biopsy Moon Sung Mo, Jung Hae Kyoung, Ko Kyung Hee, Kim Youdong, Lee Kyong Sik. Journal of Ultrasound in Medicine.2016;35(11). CrossRef
  16. Surgical implications and variability in the use of the flat epithelial atypia diagnosis on breast biopsy specimens Samples Laura S., Rendi Mara H., Frederick Paul D., Allison Kimberly H., Nelson Heidi D., Morgan Thomas R., Weaver Donald L., Elmore Joann G.. The Breast.2017;34. CrossRef
  17. Flat epithelial atypia on core needle biopsy, must we surgically excise? Acott A.A., Mancino A.T.. The American Journal of Surgery.2016;212(6). CrossRef
  18. Screening Mammograms: Interpretation with Computer-aided Detection—Prospective Evaluation Morton Marilyn J., Whaley Dana H., Brandt Kathleen R., Amrami Kimberly K.. Radiology.2006;239(2). CrossRef
  19. Systematic Review: Comparative Effectiveness of Core-Needle and Open Surgical Biopsy to Diagnose Breast Lesions Bruening Wendy. Annals of Internal Medicine.2010;152(4). CrossRef
  20. Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review Mooney Kelly L, Bassett Lawrence W, Apple Sophia K. Modern Pathology.2016;29(12). CrossRef
  21. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis Dyrstad Sara W., Yan Yan, Fowler Amy M., Colditz Graham A.. Breast Cancer Research and Treatment.2015;149(3). CrossRef
  22. Assessing the Relationship of Mammographic Breast Density and Proliferative Breast Disease Lewis Madelene C., Irshad Abid, Ackerman Susan, Cluver Abbie, Pavic Dag, Spruill Laura, Ralston Jonathan, Leddy Rebecca J.. The Breast Journal.2016;22(5). CrossRef
  23. Atypical Ductal Hyperplasia Diagnosed at Sonographically Guided Core Needle Biopsy: Frequency, Final Surgical Outcome, and Factors Associated With Underestimation Mesurolle Benoît, Perez Juan Carlos Hidalgo, Azzumea Fahad, Lemercier Emmanuelle, Xie Xuanqian, Aldis Ann, Omeroglu Atilla, Meterissian Sarkis. American Journal of Roentgenology.2014;202(6). CrossRef
  24. Management of flat epithelial atypia on breast core biopsy may be individualized based on correlation with imaging studies Calhoun Benjamin C, Sobel Amy, White Richard L, Gromet Matt, Flippo Teresa, Sarantou Terry, Livasy Chad A. Modern Pathology.2014;28(5). CrossRef
  25. Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy Murray Melissa P., Luedtke Chad, Liberman Laura, Nehhozina Tatjana, Akram Muzaffar, Brogi Edi. Cancer.2012;119(5). CrossRef
  26. Papillary neoplasms of the breast: a review Ueng SH, Mezzetti T, Tavassoli FA. Arch Pathol Lab Med.2009;133:893-907.
  27. Papillary Lesions of the Breast Diagnosed at Percutaneous Sonographically Guided Biopsy: Comparison of Sonographic Features and Biopsy Methods Shin Hee Jung, Kim Hak Hee, Kim Sun Mi, Yang Hye Rin, Sohn Jeong-Hee, Kwon Gui Young, Gong Gyungyub. American Journal of Roentgenology.2008;190(3). CrossRef
  28. Benign Papilloma on Core Biopsy Requires Surgical Excision Skandarajah Anita Rohini, Field Lee, Yuen Larn Mou Arlene, Buchanan Malcolm, Evans Jill, Hart Stewart, Mann Gregory Bruce. Annals of Surgical Oncology.2008;15(8). CrossRef
  29. The management of papillary lesion of the breast by core needle biopsy Tseng H.S., Chen Y.L., Chen S.T., Wu Y.C., Kuo S.J., Chen L.S., Wu H.K., Chen D.R.. European Journal of Surgical Oncology (EJSO).2009;35(1). CrossRef
  30. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy Jaffer Shabnam, Nagi Chandandeep, Bleiweiss Ira J.. Cancer.2009;115(13). CrossRef
  31. Risk of carcinoma after subsequent excision of benign papilloma initially diagnosed with an ultrasound (US)-guided 14-gauge core needle biopsy: a prospective observational study Chang Jung Min, Moon Woo Kyung, Cho Nariya, Han Wonshik, Noh Dong-Young, Park In-Ae, Jung Eun-Jung. European Radiology.2009;20(5). CrossRef
  32. Upgrading rate of papillary breast lesions diagnosed by core-needle biopsy Wiratkapun Cholatip, Keeratitragoon Tanaporn, Lertsithichai Panuwat, Chanplakorn Niramol. Diagnostic and Interventional Radiology.2013. CrossRef
  33. Benign Papillomas of the Breast Diagnosed on Large-Gauge Vacuum Biopsy compared with 14 Gauge Core Needle Biopsy - Do they require surgical excision? Seely Jean M., Verma Raman, Kielar Ania, Smyth Karl R., Hack Kalesha, Taljaard Monica, Gravel Denis, Ellison Erin. The Breast Journal.2016;23(2). CrossRef

Copyright

© Asian Pacific Journal of Cancer Care , 2021

Author Details

Esmat Alsadat Hashemi
Clinical Research Department, Breast Cancer Research Center, Motamed Cancer Institute,ACECR,Tehran, Iran
hashemy1277@yahoo.com

Shahpar Haghighat
Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran

Asieh Olfatbakhsh
Clinical Research Department, Breast Cancer Research Center, Motamed Cancer Institute,ACECR,Tehran, Iran

Maryam Jafari
Clinical Research Department, Breast Cancer Research Center, Motamed Cancer Institute,ACECR,Tehran, Iran

Mehrdad Yasaei
Clinical Research Department, Breast Cancer Research Center, Motamed Cancer Institute,ACECR,Tehran, Iran

How to Cite

Hashemi, E. A., Haghighat, S., Olfatbakhsh, A., Jafari, M., & Yasaei, M. (2021). Evaluation of Precancerous Breast Lesion Upgrade Rate. Asian Pacific Journal of Cancer Care, 6(4), 461-466. https://doi.org/10.31557/apjcc.2021.6.4.461-466

HTML Before

HTML After

  • Abstract viewed - 472 times
  • PDF (FULL TEXT) downloaded - 246 times
  • XML downloaded - 0 times